Presenter: Dr. Jocelyn Garland
Dr. Garland is an Associate Professor of Medicine and Nephrology at Queen’s University, where she has worked since she began her career in academic medicine in 2003. She has consistently demonstrated an avid interest in excellence in clinical care and a passion for medical education.
Dr. Garland’s teaching skills have been acknowledged by both undergraduate and post-graduate medical learners. She was the recipient of the Faculty of Medicine Phase IIE Clinical Skills Teaching Award in both 2008 and 2009. In 2015, Dr. Garland was nominated for the PARO Clinical Teaching Award for Queen’s University, and she won the Queen’s University Department of Medicine Clinical Teaching Award in 2016. Providing excellent patient care, Dr. Garland was recognized for her work as the 2017 recipient of the Ontario Renal Network/Cancer Care Ontario Provincial Human Touch Award, for which she was nominated by one of her patients. In September, 2018, she won the Royal College of Physicians and Surgeons of Canada Specialist of the Year Award, for her work in TMA.
A highly-respected clinician, Dr. Garland’s nephrology practice specializes primarily in the area of rare kidney diseases. She also participates in collaborative research initiatives, including clinical practice guidelines, and clinical trials. She is Medical Director for the Glomerulonephritis (GN)/Pregnancy in Renal Disease clinic, and of Apheresis, at Kingston Health Sciences Centre (KHSC). The overarching goal for KHSC’s GN/Pregnancy clinic is to improve access and quality of care for patients who have kidney impairment secondary to GN-related diseases. Recently, the Ontario Renal Network has recognized KHSC’s Glomerulonephritis/Pregnancy Clinic as one of six Regional GN Subspecialty Clinics in the province.
Presenter: Dr. Spero Cataland
Dr. Spero Cataland is a Professor of Internal Medicine in the Division of Hematology at the Wexner Medical Center at the Ohio State University City. He is also the co-director of the Benign Hematology Program at Ohio State University and the Director of Research. Dr. Cataland received his medical degree from Ohio State University College of Medicine and completed his residency at Ohio State University Hospital, after which he went on to hold a fellowship in hematology/oncology at the University of Chicago Medical Center. After completing his training in hematology he returned to Ohio State University where he presently remains on the faculty.
Dr. Cataland's clinical and research interests include thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uremic syndrome (aHUS) with an emphasis on acquired TTP. Dr. Cataland directs the Biomarker Reference Laboratory at Ohio State University that performs correlative laboratory studies for ongoing research projects and also serves as a reference lab for several ongoing clinical trials. Dr. Cataland has a longstanding interest in novel therapeutic approaches to acquired TTP as well as ongoing research emphasis to better understand the development of long-term complications in patients with a prior history of TTP and the mechanisms for their development. Dr. Cataland has also worked to establish the United States Thrombotic Microangiopathy Clinical Consortium, an organization of 15 academic medical centers across the United States that was organized for the purposes of conducting collaborative research in TTP and atypical haemolytic uremic syndrome.
Presenter: Dr. Susan Huang
Dr. Huang joined the Division of Nephrology and the Department of Medicine at the Schulich School of Medicine and Dentistry at Western University in July 2013. Dr. Huang is also affiliated with the Departments of Medical Biophysics and Paediatrics. She completed the certificate program in Epidemiology and Biostatistics at Western University while she was enrolled in the PhD program. In 2015, she received her PhD degree in Medical Biophysics.
During her PhD training, she received not only a CIHR Fellowship Award but also a prestigious Vanier Graduate Scholarship. She is the Director of the Home Hemodialysis Unit and the Plasmapheresis Program at the London Health Sciences Centre. She is also the lead of the Glomerulonephritis Program at the London Health Sciences Centre, which is one of the six programs that are approved by the Ontario Renal Network. Her current research projects pertain to the following three areas: optimization of dialysis therapy, application of the non-invasive imaging techniques to understand the vascular burden of thrombotic thrombocytopenic purpura and prevention in chronic kidney disease.
ASN Renal Week 2019 - Conference Update Videos
Michael J. Ross, MD
Chief of the Division of Nephrology at Montefiore
Montefiore Medical Center, the University Hospital for Albert Einstein College of MedicineWe sat down with Dr. Michael J. Ross and he informed us that Kidney Week is the highlight of the year for nephrology, where colleagues from all over the world come together to create new ideas, connect socially with peers, form new collaborations, and bring trainees along to experience all ASN has to offer.
Ian de Boer MD, MS
Professor of Medicine
University of WashingtonDr. Ian de Boer reported the results of the vital CKD trial. This trial was to determine the benefits of vitamin D or omega-3 fatty acids in regard to kidney function. As a result, vitamin D, omega-3 fatty acids do not preserve kidney function in type 2 diabetes as hoped. Read more about Dr. de Boer's results in our coverage of his talk.
Aditi Gupta, M.D. & Victor Bedros
Associate Professor, Medical Student
Kidney Institute, University of Kansas School of Medicine, University of Kansas School of MedicineAditi Gupta, M.D and Victor Bedros shared with us that they enjoy attending Kidney Week because they remain up to date with the kidney world, the latest trials, new management practices for patients, and to network with colleagues from all over the world.
Medical StudentMedical student Carolyn Murphy expressed her excitement to be a part of ASN Kidney Week, which is free for medical students to attend. ASN Kidney week gives students the opportunity to learn about cutting edge research, network with peers and identify for themselves which areas of focus they may wish to explore as they continue working toward their degrees. A great opportunity to hear about this event from the student perspective.
Director of Research
Alnylam PharmaceuticalsUnderstanding current research from leaders in the field of kidney disease is essential to researchers looking to improve treatments and treatment options. Anna Borodovsky shares a moment with us to discuss what she is most interested in from her perspective as a researcher: discoveries like new biomarkers and other as yet unpublished findings that can help her build her own research.
Dr. Dibya Singh Shah
Professor Nephrology & Transplant Medicine
Grande International Hospital, Kathmandu, NepalDr. Dibya Singh Shah has been attending Kidney Week for the last many years for the latest knowledge. This conference gives a compactsponsership for new treatments and innovations in this field since there has been an advancement in kidney transplantation.
Supported by an educational grant from Amgen Canada